as on October 15, 2025 at 1:29 am IST
Day's Low
Day's High
1.96%
Downside
1.68%
Upside
52 Week's Low
52 Week's High
61.57%
Downside
1.68%
Upside
Check Bridgebio Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$10.7B
EPS (TTM)
-2.7744
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-10.2
Industry PE ratio
8.355964912280701
PEG Ratio
0EBITDA
-623.7M
Revenue (TTM)
235.8M
Profit Margin
0.00%
Return On Equity TTM
1003092200.00%
Track how Bridgebio Pharma Inc P/E has moved over time to understand its valuation trends.
Bridgebio Pharma Inc in the last 5 years
Lowest (-15.58x)
March 31, 2021
Today (-10.20x)
October 15, 2025
Industry (8.36x)
October 15, 2025
Highest (-2.50x)
June 30, 2022
Today’s Price to Earnings Ratio: -10.20x
Compare market cap, revenue, PE, and other key metrics of Bridgebio Pharma Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $10.7B | 44.13% | -10.2 | 0.00% | |
BUY | $60.9B | 226.08% | -505.15 | -12.96% | |
NA | $37.1B | NA | NA | -3.89% | |
BUY | $104.4B | 91.48% | 28.99 | 31.86% | |
BUY | $59.1B | -2.15% | 14.07 | 31.37% |
The Bridgebio Pharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Bridgebio Pharma Inc investment value today
Current value as on today
₹2,28,463
Returns
₹1,28,463
(+128.46%)
Returns from Bridgebio Pharma Inc Stock
₹1,22,695 (+122.7%)
Dollar Returns*
₹5,768 (+5.77%)
Based on 20 analysts
85.00%
Buy
15.00%
Hold
0.00%
Sell
Based on 20 analysts, 85% of analysts recommend a 'BUY' rating for Bridgebio Pharma Inc. Average target price of $66.32
Get share price movements and forecasts by analysts on Bridgebio Pharma Inc.
What analysts predicted
14.78%UPSIDE
Target Price
$66.32
Current Price
$56.52
Analyzed by
20 Analysts
Target
$66.32
Bridgebio Pharma Inc target price $66.32, a slight upside of 14.78% compared to current price of $56.52. According to 20 analysts rating.
Search interest for Bridgebio Pharma Inc Stock has decreased by -34% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 03 September
Wed, 04:40 PM
-H.C. Wainwright also maintains Buy rating, increasing price target from $56 to $70, with all analysts rating it Buy.
Wed, 05:11 PM
-J.P. Morgan maintains Buy rating on BridgeBio, raising price target to $70, citing strong pipeline and product launch.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, BBIO has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
In the last 1 year, BBIO stock has moved up by 120.5%
Best in 3 Years
In the last 3 years, BBIO has outperformed top 5 stocks with highest market-cap in its industry
Profit Down
Netprofit is down for the last 2 quarters, -167.42M → -181.90M (in $), with an average decrease of 8.7% per quarter
Revenue Fall
Revenue is down for the last 2 quarters, 116.63M → 110.56M (in $), with an average decrease of 5.2% per quarter
Organisation | Bridgebio Pharma Inc |
Headquarters | 3160 Porter Drive, Palo Alto, CA, United States, 94304 |
Industry | Health Technology |
CEO | Dr. Neil Kumar Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Maricel M. Apuli | Chief Accounting Officer |
Dr. Uma Sinha Ph.D. | Chief Scientific Officer |
Mr. Eli M. Wallace Ph.D. | Chief Scientific Officer of Oncology |
Mr. Matthew Outten CPC, MBA | Chief Commercial Officer |
Dr. Thomas Trimarchi Ph.D. | CFO & President |
Dr. Frank P. McCormick Ph.D. | Co-Founder, Chairman of Oncology & Director |
Dr. Richard H. Scheller Ph.D. | Chairman of Research & Development |
Dr. Eric Michael David J.D., M.D., Ph.D. | Chief Executive Officer of Gene Therapy |
Dr. Neil Kumar Ph.D. | Co-Founder, CEO & Director |
Dr. Charles J. Homcy M.D. | Co-Founder, Chairman of Pharmaceuticals & Independent Lead Director |
Bridgebio Pharma Inc share price today is $56.52 as on at the close of the market. Bridgebio Pharma Inc share today touched a day high of $57.47 and a low of $55.41.
Bridgebio Pharma Inc share touched a 52 week high of $57.47 on and a 52 week low of $21.72 on . Bridgebio Pharma Inc stock price today i.e. is closed at $56.52,which is 1.65% down from its 52 week high and 160.22% up from its 52 week low.
Bridgebio Pharma Inc market capitalisation is $0.01T as on .
Indian investors can start investing in Bridgebio Pharma Inc (BBIO) shares with as little as ₹88.771 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.71 in Bridgebio Pharma Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Bridgebio Pharma Inc share’s latest price of $56.52 as on October 15, 2025 at 1:29 am IST, you will get 0.1769 shares of Bridgebio Pharma Inc. Learn more about
fractional shares .
Bridgebio Pharma Inc stock has given 44.13% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?